Mecure Industries Plc, a pharmaceutical company in Nigeria, has revealed that it has secured approval from the National Agency for Food & Drug Administration and Control (NAFDAC) to launch the production of the first locally manufactured alternative Amoxicillin-Clavulanic acid tablets, Amoxyclav
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
